Stock Research for CBLI


Featured Broker: Ally Invest

Get the due diligence for another stock.


CBLI Stock Chart & Research Data

The CBLI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CBLI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CBLI Due diligence Resources & Stock Charts

The CBLI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CBLI Detailed Price Forecast - CNN Money CNN View CBLI Detailed Summary - Google Finance
Yahoo View CBLI Detailed Summary - Yahoo! Finance Zacks View CBLI Stock Research & Analysis -

Stock Analysis

TradeIdeas View CBLI Trends & Analysis - Trade-Ideas Barrons View CBLI Major Holders - Barrons
NASDAQ View CBLI Call Transcripts - NASDAQ Seeking View CBLI Breaking News & Analysis - Seeking Alpha
Spotlight View CBLI Annual Report - OTC Report View CBLI OTC Short Report -
TradeKing View CBLI Fundamentals - TradeKing Charts View CBLI SEC Filings - Bar Chart
WSJ View Historical Prices for CBLI - The WSJ Morningstar View Performance/Total Return for CBLI - Morningstar
MarketWatch View the Analyst Estimates for CBLI - MarketWatch CNBC View the Earnings History for CBLI - CNBC
StockMarketWatch View the CBLI Earnings - StockMarketWatch MacroAxis View CBLI Buy or Sell Recommendations - MacroAxis
Bullish View the CBLI Bullish Patterns - American Bulls Short Pains View CBLI Short Pain Metrics -

Social Media Mentions

StockTwits View CBLI Stock Mentions - StockTwits PennyStocks View CBLI Stock Mentions - PennyStockTweets
Twitter View CBLI Stock Mentions - Twitter Invest Hub View CBLI Investment Forum News - Investor Hub
Yahoo View CBLI Stock Mentions - Yahoo! Message Board Seeking Alpha View CBLI Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CBLI - Insider Cow View Insider Transactions for CBLI - Insider Cow
CNBC View CBLI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CBLI - OTC Markets
Yahoo View Insider Transactions for CBLI - Yahoo! Finance NASDAQ View Institutional Holdings for CBLI - NASDAQ

Stock Charts

FinViz View CBLI Stock Insight & Charts - StockCharts View CBLI Investment Charts -
BarChart View CBLI Stock Overview & Charts - BarChart Trading View View CBLI User Generated Charts - Trading View

Latest Financial News for CBLI

Cleveland Biolabs Reports Second Quarter 2018 Financial Results And Development Progress
Posted on Tuesday August 14, 2018

BUFFALO, NY / ACCESSWIRE / August 14, 2018 / Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the second quarter ended June 30, 2018. Cleveland BioLabs ...

Cleveland Biolabs Announces Formation and Financing of an Anti-Aging Joint Venture
Posted on Tuesday August 14, 2018

BUFFALO, NY / ACCESSWIRE / August 14, 2018 / Cleveland BioLabs, Inc. (CBLI) today reported formation of a 50-50 joint venture, named Genome Protection, Inc. (GPI), between the company and Everon BioSciences, Inc. (Everon), a leader in understanding and targeting cellular mechanisms of aging and age-related diseases. GPI's goal is to develop and commercialize drugs for anti-aging applications capable of prolonging human health and life-span. CBLI and Everon contributed relevant IP, technologies and expertise to enable GPI to effectively execute an ambitious research and development program aimed at clinical testing of entolimod and development of new products for anti-aging and other indications associated with genome damage.

Cleveland BioLabs Announces Delay in Analysis of Biocomparability Data Required for Regulatory Submission
Posted on Monday August 06, 2018

BUFFALO, NY / ACCESSWIRE / August 6, 2018 / Cleveland BioLabs, Inc. (CBLI) today reported that the company has received vendor notification of delays in analytical analyses of a formulation biocomparability study required for the Company's regulatory submissions. Because the review by the United States Food and Drug Administration (FDA) of the company's pre-Emergency Use Authorization application does not take place on strict timelines, entolimod's review status with the FDA is unaffected.

Ikea’s departure from Cary leads to impairment charge for mall owner
Posted on Friday June 22, 2018

In the wake of Ikea’s departure from Cary Towne Center, the mall’s owner is moving toward an impairment charge on its books, according to public filings from the company.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.